• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于证据的规划:使用可变形配准减少现代肺部立体定向消融放疗的靶区边缘

Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration.

作者信息

Jasper Katie, Liu Baochang, Olson Robert, Matthews Quinn

机构信息

BC Cancer-Vancouver, Vancouver, British Columbia, Canada.

Division of Radiation Oncology, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Adv Radiat Oncol. 2021 Jul 3;6(6):100750. doi: 10.1016/j.adro.2021.100750. eCollection 2021 Nov-Dec.

DOI:10.1016/j.adro.2021.100750
PMID:34401609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8349747/
Abstract

PURPOSE

Standard planning target volume (PTV) margins for lung stereotactic ablative radiation therapy (SABR) are 5 mm. High-dose-rate volumetric modulated arc therapy delivered using flattening filter-free (FFF) beams with modern immobilization systems may allow for PTV margin reduction. This study assesses whether PTV margins can be reduced from 5 to 3 mm.

METHODS

Target intrafractional motions derived from pretreatment and posttreatment cone beam computed tomography (CBCT) scans for 33 patients receiving lung SABR treated with 10XFFF energy and 5-mm PTV margins from 2016 to 2019 were used to calculate the required PTV margin. Deformable registration of the planning CT scan and internal gross tumor volume (IGTV) contour to posttreatment CBCT scans for 36 consecutive patients with 4 fraction schedules was completed to capture volume changes and intrafractional movement. Plans were replanned with 3-mm margins and recalculated on each deformed CT scan to assess deformed IGTV (d-IGTV) coverage and organ-at-risk doses.

RESULTS

Margin analysis showed PTV margins may be reduced to 3 mm. The mean d-IGTV coverage (percentage of the d-IGTV receiving ≥100% of the prescription dose [V100%] and the minimum dose covering 99.9% of the d-IGTV volume [D99.9%]) over 4 fractions for each patient was >95% with both margins. With 5-mm PTV margins, all 144 fractions had a d-IGTV V100% of >95% and a D99.9% >95%. With 3-mm PTV margins, the d-IGTV V100% was >95% in 99.3% of fractions (143 of 144) and the D99.9% was >95% in 98.6% of fractions (142 of 144). With 3-mm PTV margins, significant reductions in body V50%, body V80%, the volume of the lung receiving ≥20 Gy, and the mean lung dose and chest wall dose to 0.035 cm and 30 cm were observed (all < .001). Using theoretical models, the normal tissue complication probability for radiation pneumonitis decreased by a mean of 0.8% (range, 0.1%-2.7%), and the mean 2-year tumor control probability was 96.1% and 95.2% with 5-mm and 3-mm PTV margins, respectively.

CONCLUSION

With modern treatment and immobilization techniques in lung SABR, 3-mm PTV margins maintain acceptable IGTV coverage, modestly reduce toxicity to organs at risk, and maintain a calculated 2-year local control rate of >95%.

摘要

目的

肺部立体定向消融放疗(SABR)的标准计划靶区(PTV)边界为5毫米。使用无 flattening 滤波器(FFF)束流并结合现代固定系统进行的高剂量率容积调强弧形放疗,可能允许减少PTV边界。本研究评估PTV边界是否可以从5毫米减少到3毫米。

方法

利用2016年至2019年期间接受肺部SABR治疗、采用10XFFF能量和5毫米PTV边界的33例患者治疗前和治疗后的锥形束计算机断层扫描(CBCT)扫描得出的靶区内分次运动,来计算所需的PTV边界。对连续36例接受4分次治疗方案的患者,完成计划CT扫描与内部大体肿瘤体积(IGTV)轮廓到治疗后CBCT扫描的可变形配准,以捕捉体积变化和分次内运动。采用3毫米边界重新规划计划,并在每次变形的CT扫描上重新计算,以评估变形后的IGTV(d-IGTV)覆盖情况和危及器官的剂量。

结果

边界分析表明PTV边界可减少至3毫米。两种边界情况下,每位患者4次分次治疗中d-IGTV的平均覆盖情况(接受≥100%处方剂量的d-IGTV百分比[V100%]以及覆盖99.9%的d-IGTV体积的最小剂量[D99.9%])均>95%。采用5毫米PTV边界时,144次分次治疗中所有d-IGTV的V-100%均>95%且D99.9%>95%。采用3毫米PTV边界时,99.3%的分次治疗(144次中的143次)中d-IGTV的V100%>95%,98.6%的分次治疗(144次中的142次)中D99.9%>95%。采用3毫米PTV边界时,观察到身体V50%、身体V80%、接受≥20 Gy的肺体积以及至0.035厘米和30厘米处的平均肺剂量和胸壁剂量均显著降低(均<.001)。使用理论模型,放射性肺炎的正常组织并发症概率平均降低0.8%(范围为0.1%-2.7%),5毫米和3毫米PTV边界时的平均2年肿瘤控制概率分别为96.1%和95.2%。

结论

在肺部SABR中采用现代治疗和固定技术时,3毫米的PTV边界可维持可接受的IGTV覆盖,适度降低对危及器官的毒性,并维持计算得出的>95%的2年局部控制率。

相似文献

1
Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration.基于证据的规划:使用可变形配准减少现代肺部立体定向消融放疗的靶区边缘
Adv Radiat Oncol. 2021 Jul 3;6(6):100750. doi: 10.1016/j.adro.2021.100750. eCollection 2021 Nov-Dec.
2
Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.头颈部癌症中通过概率治疗计划将患者几何变化纳入自适应计划优化的剂量学评估。
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):985-997. doi: 10.1016/j.ijrobp.2018.03.062. Epub 2018 Apr 5.
3
Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam.使用无均整器射束优化肺部立体定向体部放射治疗的射野边缘。
Med Phys. 2015 May;42(5):2125-31. doi: 10.1118/1.4916683.
4
Does Motion Assessment With 4-Dimensional Computed Tomographic Imaging for Non-Small Cell Lung Cancer Radiotherapy Improve Target Volume Coverage?使用四维计算机断层扫描成像进行非小细胞肺癌放疗的运动评估是否能改善靶区覆盖?
Clin Med Insights Oncol. 2017 Mar 14;11:1179554917698461. doi: 10.1177/1179554917698461. eCollection 2017.
5
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.评估蒙特卡罗算法在接受立体定向体部放射治疗的周围型肺癌患者中符合 RTOG 0915 剂量学标准的应用。
J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077.
6
Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.容积旋转调强弧形治疗技术在胸段食管癌大靶区中的应用。
J Appl Clin Med Phys. 2013 May 6;14(3):4269. doi: 10.1120/jacmp.v14i3.4269.
7
ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.在肺部 SBRT 治疗计划中,使用治疗中 4D 锥形束 CT 比较 ITV 与中通气时的靶区覆盖和 PTV 适形度。
Radiat Oncol. 2020 Mar 3;15(1):54. doi: 10.1186/s13014-020-01496-5.
8
Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.在平均呼吸位置进行剂量递增肝脏立体定向体部放射治疗。
Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1121-1128. doi: 10.1016/j.ijrobp.2014.04.051. Epub 2014 Jul 8.
9
Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.使用治疗中 4D 锥形束 CT 对立体定向体部放射治疗的容积调强弧形治疗计划靶区设置进行验证。
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):426-31. doi: 10.1016/j.ijrobp.2013.02.019. Epub 2013 Apr 5.
10
Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration.在深吸气时屏气对肺部肿瘤进行固定的剂量学评估。
Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1091-8. doi: 10.1016/s0360-3016(01)01592-9.

引用本文的文献

1
Application of respiratory motion management technology for patients with lung cancer treated with stereotactic body radiotherapy (Review).立体定向体部放疗治疗肺癌患者的呼吸运动管理技术应用(综述)
Oncol Lett. 2025 Jun 27;30(3):415. doi: 10.3892/ol.2025.15161. eCollection 2025 Sep.
2
SGRT-based stereotactic body radiotherapy for lung cancer setup accuracy and margin of the PTV.基于体表图像引导放疗的立体定向体部放疗用于肺癌的摆位精度和计划靶区边界
J Appl Clin Med Phys. 2024 Mar;25(3):e14195. doi: 10.1002/acm2.14195. Epub 2023 Nov 1.
3
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.

本文引用的文献

1
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌,2022年第3版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2022 May;20(5):497-530. doi: 10.6004/jnccn.2022.0025.
2
The evolving toxicity profile of SBRT for lung cancer.立体定向体部放疗治疗肺癌时不断演变的毒性特征。
Transl Lung Cancer Res. 2019 Feb;8(1):48-57. doi: 10.21037/tlcr.2018.10.06.
3
A method for optimizing planning target volume margins for patients receiving lung stereotactic body radiotherapy.
加拿大OCOG-LUSTRE随机试验中的肺部立体定向体部放疗认证
Clin Transl Radiat Oncol. 2022 Oct 13;37:145-152. doi: 10.1016/j.ctro.2022.10.002. eCollection 2022 Nov.
一种优化接受肺部立体定向体放射治疗的患者计划靶区边缘的方法。
Phys Med Biol. 2018 Oct 2;63(19):195015. doi: 10.1088/1361-6560/aadf26.
4
Comparison of residual geometric errors obtained for lung SBRT under static beams and VMAT techniques: Implications for PTV margins.静态射野和容积调强弧形治疗(VMAT)技术下肺立体定向体部放疗(SBRT)的残余几何误差比较:对计划靶区(PTV)边界的影响
Phys Med. 2018 Aug;52:129-132. doi: 10.1016/j.ejmp.2018.07.009. Epub 2018 Jul 30.
5
Stereotactic body radiotherapy for central lung tumors: Finding the balance between safety and efficacy in the "no fly" zone.立体定向体部放疗治疗中央型肺部肿瘤:在“禁飞区”寻找安全性与疗效的平衡。
Thorac Cancer. 2018 Oct;9(10):1211-1214. doi: 10.1111/1759-7714.12764. Epub 2018 Aug 10.
6
Deformable image registration in radiation therapy.放射治疗中的可变形图像配准
Radiat Oncol J. 2017 Jun;35(2):101-111. doi: 10.3857/roj.2017.00325. Epub 2017 Jun 30.
7
Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.立体定向体部放疗治疗胸腹部肿瘤的运动管理策略和技术问题:NRG 肿瘤学的综述。
Med Phys. 2017 Jun;44(6):2595-2612. doi: 10.1002/mp.12227. Epub 2017 Apr 20.
8
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.加拿大针对I期医学上无法手术的非小细胞肺癌开展的立体定向体部放疗与传统低分割放疗的III期随机试验——安大略临床肿瘤学组(OCOG)-LUSTRE试验的原理与方案设计
Clin Lung Cancer. 2017 Mar;18(2):250-254. doi: 10.1016/j.cllc.2016.08.002. Epub 2016 Oct 3.
9
Dosimetric differences in flattened and flattening filter-free beam treatment plans.均整滤过与无均整滤过射束治疗计划中的剂量学差异。
J Med Phys. 2016 Apr-Jun;41(2):92-9. doi: 10.4103/0971-6203.181636.
10
Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung Cancer.“超中心型”低危非小细胞肺癌患者接受大分割高剂量放疗的结果。
J Thorac Oncol. 2016 Jul;11(7):1081-9. doi: 10.1016/j.jtho.2016.03.008. Epub 2016 Mar 21.